Kubota Pharmaceutical Holdings Co., Ltd. (TYO:4596)
148.00
+23.00 (18.40%)
At close: Feb 6, 2026
TYO:4596 Revenue
Kubota Pharmaceutical Holdings had revenue of 5.46M JPY in the quarter ending September 30, 2025, a decrease of -25.98%. This brings the company's revenue in the last twelve months to 28.27M, up 6.74% year-over-year. In the year 2024, Kubota Pharmaceutical Holdings had annual revenue of 27.00M, down -30.77%.
Revenue (ttm)
28.27M
Revenue Growth
+6.74%
P/S Ratio
604.27
Revenue / Employee
1.49M
Employees
19
Market Cap
17.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 27.00M | -12.00M | -30.77% |
| Dec 31, 2023 | 39.00M | 31.00M | 387.50% |
| Dec 31, 2022 | 8.00M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 37.00M | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kidswell Bio | 6.61B |
| StemCell Institute | 2.72B |
| ReproCELL | 2.63B |
| Immuno-Biological Laboratories | 1.01B |
| Stella Pharma | 992.00M |
| CellSeed | 161.00M |
| Nano Holdings | 142.00M |
| Renascience | 87.00M |